Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A42372 | 34741326 | Aliment Pharmacol Ther | Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity. | 2021 | Details |
| A42384 | 34708367 | MMW Fortschr Med | 2021 | Details | |
| A42386 | 34704503 | Crit Rev Food Sci Nutr | Effects and mechanisms of tea on obesity. | 2021 | Details |
| A42390 | 34697893 | J Dig Dis | Multidisciplinary participation: The key to a cure for non-alcoholic fatty liver disease. | 2021 | Details |
| A42392 | 34689140 | Horm Res Paediatr | Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion. | 2021 | Details |
| A42396 | 34674606 | Gut Microbes | Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? | 2022 | Details |
| A42402 | 34633856 | Annu Rev Nutr | Microbial Flavonoid Metabolism: A Cardiometabolic Disease Perspective. | 2021 | Details |
| A42405 | 34626045 | Liver Transpl | A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients. | 2021 | Details |
| A42406 | 34621322 | Evid Based Complement Alternat Med | YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats. | 2021 | Details |
| A42414 | 34600840 | J Clin Lipidol | Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome. | 2021 | Details |
| A42446 | 34509980 | Gut | Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed. | 2021 | Details |
| A42477 | 34436472 | Metabolites | The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions. | 2021 | Details |
| A42479 | 34427594 | JAMA | Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. | 2021 | Details |
| A42553 | 34172646 | Transplantation | Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. | 2022 | Details |
| A42556 | 34165872 | Liver Transpl | Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival. | 2021 | Details |
| A42559 | 34163039 | Nat Rev Endocrinol | Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus. | 2021 | Details |
| A42571 | 34142426 | Diabetes Obes Metab | Sodium-glucose cotransporter-2 inhibitors for type 2 diabetes mellitus in adults: An overview of 46 systematic reviews. | 2021 | Details |
| A42586 | 34105827 | J Gastroenterol Hepatol | Liver-heart connection in diabetes mellitus. | 2021 | Details |
| A42604 | 34046909 | Med J Aust | Non-alcoholic fatty liver disease: raising awareness of a looming public health problem. | 2021 | Details |
| A42620 | 33989632 | Metabolism | Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: Is it time to give the emperor a statin robe? | 2021 | Details |
| A42624 | 33983128 | Interact J Med Res | Relevance of Anthropometric Measurements in a Multiethnic Obesity Cohort: Observational Study. | 2021 | Details |
| A42625 | 33981216 | Front Pharmacol | Analysis of Time Course and Dose Effect From Metformin on Body Mass Index in Children and Adolescents. | 2021 | Details |
| A42632 | 33960005 | Hepatology | The Glucagon-Like Peptide-1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A42634 | 33953469 | Proc (Bayl Univ Med Cent) | Persistent lactic acidosis in the Mauriac syndrome in type 1 diabetes mellitus. | 2021 | Details |
| A42666 | 33849008 | J Innate Immun | Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease. | 2021 | Details |
| A42677 | 33819416 | J Pediatr Endocrinol Metab | Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children. | 2021 | Details |
| A42691 | 33758643 | World J Diabetes | Progress on haptoglobin and metabolic diseases. | 2021 | Details |
| A42696 | 33739235 | Crit Rev Clin Lab Sci | Potential value and impact of data mining and machine learning in clinical diagnostics. | 2021 | Details |
| A42703 | 33717101 | Front Immunol | Natural Killer Cells: Friend or Foe in Metabolic Diseases? | 2021 | Details |
| A42708 | 33682953 | Nutr Clin Pract | Endogenous Glucose Production in Critical Illness. | 2021 | Details |
| A42709 | 33682344 | FEBS J | Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. | 2021 | Details |
| A42712 | 33674915 | J Gen Intern Med | Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018. | 2021 | Details |
| A42716 | 33659163 | J Med Ultrasound | Ultrasonographic Features Associated with Diffuse Hepatosteatosis among Diabetic Obese and Normal Body Mass Index Patients. | 2020 | Details |
| A42736 | 33604315 | J Hepatocell Carcinoma | Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. | 2021 | Details |
| A42744 | 33595181 | Liver Int | Liver chemistries in glycogenic hepatopathy associated with type 1 diabetes mellitus: A systematic review and pooled analysis. | 2021 | Details |
| A42749 | 33586126 | Am J Clin Dermatol | Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges. | 2021 | Details |
| A42758 | 33561215 | J Nutr | Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study. | 2021 | Details |
| A42765 | 33535939 | Exp Clin Transplant | Liver Transplantation in Alstrom Syndrome: A Case Report. | 2021 | Details |
| A42780 | 33497712 | Metabolism | Role of the gut microbiota in type 2 diabetes and related diseases. | 2021 | Details |
| A42784 | 33485519 | Am J Kidney Dis | Clinical Approach to a Patient With an Acid-Base Disturbance. | 2021 | Details |
| A42787 | 33479538 | Nat Rev Endocrinol | Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. | 2021 | Details |
| A42825 | 33345412 | Liver Transpl | Nonalcoholic Fatty Liver Disease: A Special Consideration in Transjugular Intrahepatic Portosystemic Shunts? | 2021 | Details |
| A42836 | 33337742 | Clin Obstet Gynecol | Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health. | 2021 | Details |
| A42863 | 33259630 | Toxicol Sci | Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring. | 2020 | Details |
| A42874 | 33247737 | Toxicol Sci | Inhibition of Acetyl-CoA Carboxylase Causes Malformations in Rats and Rabbits: Comparison of Mammalian Findings and Alternative Assays. | 2021 | Details |
| A42889 | 33189580 | Can J Diabetes | Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes. | 2020 | Details |
| A42912 | 33123088 | Front Endocrinol (Lausanne) | The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. | 2020 | Details |
| A42952 | 32979160 | Dig Dis Sci | NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease. | 2020 | Details |
| A42972 | 32923832 | Hepatol Commun | Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis. | 2020 | Details |
| A42978 | 32899741 | Life (Basel) | Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study. | 2020 | Details |
| A42987 | 32886383 | Aliment Pharmacol Ther | Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD. | 2020 | Details |
| A42988 | 32886382 | Aliment Pharmacol Ther | Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD-Authors' reply. | 2020 | Details |
| A43001 | 32850201 | Cureus | Glycogenic Hepatopathy: A Reversible Complication of Uncontrolled Diabetes Mellitus. | 2020 | Details |
| A43008 | 32829627 | J Biol Regul Homeost Agents | Potential influence of miR-192 on the efficacy of saxagliptin treatment in T2DM complicated with non-alcoholic fatty liver disease. | 2021 | Details |
| A43012 | 32814360 | J Diabetes Investig | In search of the optimal management strategy for non-alcoholic fatty liver disease in type 2 diabetes patients. | 2020 | Details |
| A43021 | 32795106 | Metab Syndr Relat Disord | Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Does it Matter? | 2020 | Details |
| A43030 | 32763241 | Gastroenterology | Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis. | 2020 | Details |
| A43038 | 32740703 | Acta Diabetol | Nonalcoholic fatty liver disease and cardiovascular risk in severely obese adolescents. | 2020 | Details |
| A43054 | 32692117 | J Clin Gastroenterol | Longitudinal Change in Simple Scores Identifies Fibrosis Status in People With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43061 | 32668489 | J Viral Hepat | Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. | 2020 | Details |
| A43066 | 32646248 | Expert Opin Drug Discov | What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline. | 2020 | Details |
| A43071 | 32637065 | Ther Adv Endocrinol Metab | Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. | 2020 | Details |
| A43082 | 32613782 | Diabetes Metab J | Response: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267-76). | 2020 | Details |
| A43083 | 32613780 | Diabetes Metab J | Letter: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267-76). | 2020 | Details |
| A43087 | 32598598 | Ter Arkh | [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features]. | 2019 | Details |
| A43093 | 32587620 | Stem Cells Int | Human Adipose Derived Cells in Two- and Three-Dimensional Cultures: Functional Validation of an In Vitro Fat Construct. | 2020 | Details |
| A43124 | 32493714 | Diabetes | Phenotypic and Genetic Characterization of Lower LDL Cholesterol and Increased Type 2 Diabetes Risk in the UK Biobank. | 2020 | Details |
| A43137 | 32454183 | Hellenic J Cardiol | Diabetes mellitus and comorbidities: A bad romance. | 2020 | Details |
| A43145 | 32431189 | J Am Heart Assoc | Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events. | 2020 | Details |
| A43146 | 32431101 | Diabetes Metab J | A Comparison of Predictive Performances between Old versus New Criteria in a Risk-Based Screening Strategy for Gestational Diabetes Mellitus. | 2020 | Details |
| A43171 | 32378399 | J Obes Metab Syndr | Current Long-Term Pharmacotherapies for the Management of Obesity. | 2020 | Details |
| A43173 | 32374328 | Biomater Sci | A versatile ultrafine and super-absorptive H+-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection. | 2020 | Details |
| A43182 | 32355690 | Hepatobiliary Surg Nutr | Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus? | 2020 | Details |
| A43186 | 32352234 | Liver Int | Redefining fatty liver disease classification in 2020. | 2020 | Details |
| A43281 | 32072735 | Diabetes Obes Metab | Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes. | 2020 | Details |
| A43284 | 32069155 | Diabetes Technol Ther | NAFLD/NASH and Diabetes. | 2020 | Details |
| A43291 | 32048880 | Future Med Chem | Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs. | 2020 | Details |
| A43313 | 32006524 | Transl Res | Role of placental fibrinogen-like protein 1 in gestational diabetes. | 2020 | Details |
| A43326 | 31979903 | J Assoc Physicians India | Saroglitazar Improves Transaminases and Elastography in Patients with Diabetic Dyslipidemia and Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A43327 | 31979865 | J Assoc Physicians India | Prevalence of Non Alcoholic Fatty Pancreatic Disease (NAFPD) in General Adult Population and its Association with Type 2 Diabetes Mellitus. | 2020 | Details |
| A43329 | 31979848 | J Assoc Physicians India | A Study of Non?Alcoholic Fatty Liver Disease in Type II Diabetes. | 2020 | Details |
| A43334 | 31979574 | J Assoc Physicians India | To Study the Occurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type -II Diabetes Mellitus. | 2020 | Details |
| A43335 | 31979568 | J Assoc Physicians India | Assessment of Risk Factors for Cardiovascular Morbidity in Type 2 DM with and Without Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A43340 | 31959644 | Diabetes Care | Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes. | 2020 | Details |
| A43344 | 31945627 | Nutr Res | A maple syrup extract alleviates liver injury in type 2 diabetic model mice. | 2019 | Details |
| A43360 | 31909364 | J Obes Metab Syndr | Effect of Diet on the Gut Microbiota Associated with Obesity. | 2019 | Details |
| A43362 | 31904864 | Hepatology | Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43365 | 31903611 | Hepatology | Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management. | 2020 | Details |
| A43367 | 31901172 | Hepatology | Reply. | 2020 | Details |
| A43368 | 31901147 | Hepatology | REPLY. | 2020 | Details |
| A43374 | 33777267 | Prz Gastroenterol | Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients. | 2020 | Details |
| A43383 | 31860928 | Exp Clin Endocrinol Diabetes | Diabetes and Fatty Liver. | 2019 | Details |
| A43392 | 31850557 | Aliment Pharmacol Ther | Commentary: advances in the pharmacotherapy of NASH-anti-diabetic drugs and beyond. | 2020 | Details |
| A43395 | 31845444 | Phytother Res | Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice. | 2019 | Details |
| A43418 | 31765518 | J Diabetes Investig | Are the polyol pathway and hyperuricemia partners in the development of non-alcoholic fatty liver disease in diabetes? | 2020 | Details |
| A43419 | 31764586 | J Hypertens | Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient. | 2020 | Details |
| A43425 | 31754898 | Curr Diab Rep | Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. | 2019 | Details |
| A43429 | 31737665 | Biomed Res Int | Lipid Metabolism Alterations in a Rat Model of Chronic and Intergenerational Exposure to Arsenic. | 2019 | Details |
| A43430 | 31737070 | Int J Endocrinol | Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications. | 2019 | Details |
| A43434 | 31722058 | Dig Dis Sci | Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C. | 2019 | Details |